Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), Carmine Zoccali(Università Campus Bio-Medico), Patrick Rossignol(Inserm), Mehmet Kanbay(Koç University), Francesca Mallamaci(Metabolism and Renal Physiology), Michel Jadoul(Cliniques Universitaires Saint-Luc), Luís M. Ruilope, Gérard M. London(Hôpital Européen Georges-Pompidou), Alexandre Persu(Cliniques Universitaires Saint-Luc), Patrick B. Mark(University of Glasgow), Andrzej Więcek(Medical University of Silesia), Patricia Van der Niepen(Universitair Ziekenhuis Brussel), Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Alberto Ortíz(Fundación Renal), F. Jarraya(University of Sfax), Marianne C. Verhaar(Utrecht University), Jean‐Michel Halimi(Université de Tours), Michel Burnier(University of Lausanne), Roberto Pontremoli(Ospedale Policlinico San Martino), Raymond Vanholder(Baylor College of Medicine), Grégoire Wuerzner(University of Lausanne), Gunnar H. Heine(Saarland University), Peter de Leeuw, Gianfranco Parati(University of Milano-Bicocca)
Cited by 225
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k